Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:02310773n
Noun Concept
ES
No term available
EN
Bcr-Abl tyrosine-kinase inhibitors are the first-line therapy for most patients with chronic myelogenous leukemia. Wikipedia
Relations
Sources
IS A
inhibidor de la tirosina quinasa

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License